BOOK
Advances in Surgery, E-Book
John L. Cameron | Timothy G. Buchman | K. Craig Kent | Keith Lillemoe | Kelly M. McMasters | Mark Talamini | Charles J. Yeo
(2016)
Additional Information
Book Details
Abstract
Each year, Advances in Surgery reviews the most current practices in general surgery. A distinguished editorial board, headed by Dr. John Cameron, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in general surgery bring concepts to a clinical level and explore their everyday impact on patient care.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Advances In Surgery\r | i | ||
Volumes 1 through 45 (out of print) | iii | ||
Volume 49 | iii | ||
Volume 48 | iv | ||
Volume 47 | v | ||
Volume 46 | vi | ||
Copyright\r | ix | ||
CONTRIBUTORS\r | xiii | ||
CONTENTS\r | xvii | ||
Management of Mixed-Type Intraductal Papillary Mucinous Neoplasm | xvii | ||
Minimally Invasive Esophagectomy: Is There an Advantage? | xvii | ||
Optimal Management of the Axilla: A Look at the Evidence | xviii | ||
The Use of LINX for Gastroesophageal Reflux | xviii | ||
Bowel Preparation: Are Antibiotics Necessary for Colorectal Surgery? | xviii | ||
Incarcerated/Strangulated Hernia: Open or Laparoscopic? | xix | ||
Strategies to Reduce Postoperative Urinary Tract Infections | xix | ||
The Aging Surgeon | xix | ||
Maintenance of Certification | xix | ||
Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma | xx | ||
Prevention of Perioperative Anastomotic Healing Complications: Anastomotic Stricture and Anastomotic Leak | xx | ||
Is Health Services Research Important for Surgeons? | xx | ||
Robotic Colorectal Surgery: Advance or Expense? | xxi | ||
Ventilator Management: A Systematic Approach to Choosing and Using New Modes | xxi | ||
Hernia Management in the Athlete | xxi | ||
Groin Pain After Inguinal Hernia Repair | xxii | ||
Evolution of Sepsis Management: From Early Goal-Directed Therapy to Personalized Care | xxii | ||
Current Status of Carotid Stenting Versus Endarterectomy | xxii | ||
Management of Mixed-Type Intraductal Papillary Mucinous Neoplasm | 1 | ||
Key points | 1 | ||
INTRODUCTION | 1 | ||
DEFINITION | 2 | ||
Radiographic | 2 | ||
Pathologic | 3 | ||
CLINICOPATHOLOGIC CHARACTERISTICS | 3 | ||
Epidemiology | 3 | ||
Clinical and radiographic presentation | 4 | ||
Pathology | 4 | ||
CLASSIFICATION | 4 | ||
Radiographic versus pathologic classification | 4 | ||
Limitation of radiographic classification | 5 | ||
Heterogeneity of main-duct involvement: proposed subclassifications of mixed-type intraductal papillary mucinous neoplasm | 5 | ||
Pathologic subtype in mixed-type intraductal papillary mucinous neoplasm | 6 | ||
NATURAL HISTORY | 6 | ||
Malignancy risk | 6 | ||
Surveillance | 7 | ||
Predictors of malignancy | 8 | ||
Survival and recurrence | 9 | ||
MANAGEMENT | 10 | ||
Indications for surgery | 10 | ||
Surgical decision making | 10 | ||
Nonsurgical management | 12 | ||
SUMMARY | 12 | ||
References | 13 | ||
Minimally Invasive Esophagectomy | 17 | ||
INTRODUCTION | 17 | ||
HISTORICAL NOTE | 18 | ||
RELATIONSHIP BETWEEN ANASTOMOTIC LEAK AND OPERATIVE MORTALITY | 19 | ||
COMPARISON OF THE TRANSHIATAL AND TRANSTHORACIC ESOPHAGECTOMIES | 21 | ||
MINIMALLY INVASIVE ESOPHAGECTOMY USING LAPAROSCOPIC AND THORACOSCOPIC TECHNIQUES | 23 | ||
IS THERE AN OPTIMAL SURGICAL TECHNIQUE FOR PERFORMING ESOPHAGECTOMY? | 24 | ||
DEVELOPMENT OF A MAXIMALLY EFFECTIVE ESOPHAGECTOMY | 26 | ||
References | 27 | ||
Optimal Management of the Axilla | 29 | ||
INTRODUCTION | 29 | ||
DEVELOPMENT OF LYMPHATIC MAPPING AND SENTINEL LYMPH NODE BIOPSY | 30 | ||
Single-institution and multicenter studies of sentinel lymph node biopsy | 30 | ||
Randomized trials of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus axillary lymph node dissection ... | 31 | ||
Clinical significance of occult sentinel lymph node metastases | 32 | ||
Randomized trials of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus axillary lymph node dissection ... | 32 | ||
Assessment of axillary nodal status in patients treated with neoadjuvant chemotherapy | 34 | ||
Sentinel lymph node biopsy in patients treated with neoadjuvant chemotherapy | 34 | ||
Single-institution studies of sentinel lymph node biopsy after neoadjuvant chemotherapy | 29 | ||
Multicenter studies of sentinel node biopsy after neoadjuvant chemotherapy | 35 | ||
Meta-analysis of studies evaluating sentinel lymph node biopsy after neoadjuvant chemotherapy | 35 | ||
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with known axillary involvement at diagnosis | 35 | ||
Sentinel lymph node biopsy before neoadjuvant chemotherapy: advantages and limitations | 37 | ||
References | 38 | ||
The Use of LINX for Gastroesophageal Reflux | 41 | ||
HISTORY | 41 | ||
MAGNETIC ANTIREFLUX DEVICE | 42 | ||
PATIENT SELECTION | 43 | ||
SURGICAL TECHNIQUE | 44 | ||
CONTRAINDICATIONS | 45 | ||
EFFICACY | 46 | ||
COMPLICATIONS | 47 | ||
SUMMARY | 47 | ||
References | 47 | ||
Bowel Preparation | 49 | ||
Key points | 49 | ||
INTRODUCTION: BACKGROUND | 49 | ||
SIGNIFICANCE | 50 | ||
MECHANICAL BOWEL PREPARATION ALONE | 51 | ||
COLONIC BACTERIA | 53 | ||
MECHANICAL BOWEL PREPARATION PLUS ORAL ANTIBIOTICS | 54 | ||
MECHANICAL BOWEL PREPARATION PLUS IV ANTIBIOTICS (WITH OR WITHOUT ORAL) | 57 | ||
CURRENT EVIDENCE | 58 | ||
RECTUM VERSUS COLON | 61 | ||
ROLE OF ENEMA | 62 | ||
LAPAROSCOPIC VERSUS OPEN | 62 | ||
PRESENT RELEVANCE AND FUTURE AVENUES | 62 | ||
SUMMARY | 62 | ||
References | 63 | ||
Incarcerated/Strangulated Hernia | 67 | ||
INTRODUCTION | 67 | ||
DIAGNOSIS | 68 | ||
DECISION-MAKING | 70 | ||
Incarcerated/strangulated inguinal hernia | 70 | ||
SURGICAL APPROACHES—LAPAROSCOPY | 71 | ||
Laparoscopic repair for adults | 71 | ||
Laparoscopic repair for children | 73 | ||
SURGICAL APPROACHES—OPEN | 74 | ||
Open repair for adults | 74 | ||
Open repair for children | 75 | ||
SUMMARY | 76 | ||
References | 76 | ||
Strategies to Reduce Postoperative Urinary Tract Infections | 79 | ||
INTRODUCTION | 79 | ||
SIGNIFICANCE | 80 | ||
PREVENTION OF CATHETER-ASSOCIATED URINARY TRACT INFECTION | 82 | ||
Sterile catheter techniques | 83 | ||
Types of catheters | 84 | ||
Indications for catheterization | 84 | ||
Timing of catheter removal | 84 | ||
Reducing postoperative urinary retention | 85 | ||
Prophylactic antibiotics | 87 | ||
Screening for asymptomatic bacteriuria | 87 | ||
SUMMARY | 88 | ||
References | 89 | ||
The Aging Surgeon | 93 | ||
INTRODUCTION | 93 | ||
CASE REPORT | 94 | ||
IS THE AGING SURGEON STILL A PROBLEM? | 94 | ||
ARE SURGEONS HUMAN? | 95 | ||
IS A MANDATORY RETIREMENT AGE THE ANSWER? | 97 | ||
BUT DOES THE SURGICAL PROFESSION POLICE ITSELF? | 98 | ||
THE AGING SURGEON PROGRAM | 99 | ||
SUMMARY | 102 | ||
References | 102 | ||
Maintenance of Certification | 105 | ||
BACKGROUND | 105 | ||
RECERTIFICATION ESTABLISHED | 107 | ||
INTRODUCTION OF MAINTENANCE OF CERTIFICATION | 107 | ||
REQUIREMENTS FOR THE AMERICAN BOARD OF SURGERY MAINTENANCE OF CERTIFICATION PROGRAM | 109 | ||
RELEVANCE OF AMERICAN BOARD OF SURGERY MAINTENANCE OF CERTIFICATION | 111 | ||
References | 113 | ||
Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma | 115 | ||
INTRODUCTION | 115 | ||
SIGNIFICANCE OF RESECTABILITY | 116 | ||
NEOADJUVANT CHEMOTHERAPY | 117 | ||
FOLFIRINOX | 117 | ||
Gemcitabine-based therapy | 115 | ||
NEOADJUVANT CHEMORADIATION | 119 | ||
SURGICAL RESECTION AND INTRAOPERATIVE THERAPY | 120 | ||
Intraoperative Radiotherapy | 121 | ||
Intraoperative Electroporation | 122 | ||
ADJUVANT THERAPY | 122 | ||
FUTURE DIRECTIONS | 123 | ||
SUMMARY | 124 | ||
References | 124 | ||
Prevention of Perioperative Anastomotic Healing Complications | 129 | ||
ANASTOMOTIC COMPLICATIONS: A SPECTRUM OF CLINICAL PRESENTATIONS | 129 | ||
BEYOND TENSION AND ISCHEMIA: PHYSICS IS IMPORTANT, BUT BIOLOGY IS A MAJOR FACTOR IN ANASTOMOTIC HEALING | 130 | ||
CURRENT UNDERSTANDING: WE HAVE PROBABILISTIC MEASUREMENTS AND WE NOW NEED DETERMINISTIC ANALYSES | 131 | ||
Anastomotic stricture | 131 | ||
Anastomotic leak | 131 | ||
THE CHALLENGE OF DEFINING ANASTOMOTIC HEALING COMPLICATIONS | 132 | ||
Anastomotic stricture | 132 | ||
Anastomotic leak | 133 | ||
SPECIFIC INTERVENTIONS TO PREVENT ANASTOMOTIC HEALING COMPLICATIONS | 133 | ||
Anastomotic stricture | 133 | ||
Anastomotic leak: hand sewn versus stapling, intraoperative evaluation, and diverting ileostomy | 134 | ||
THE BIOLOGY OF ANASTOMOTIC HEALING | 135 | ||
MICROBES: THE COMMON DENOMINATOR OF ANASTOMOTIC COMPLICATIONS? | 136 | ||
PREPARING THE BOWEL FOR ANASTOMOTIC SURGERY: HOW WE GOT IT RIGHT, WHY WE STILL HAVE IT WRONG | 137 | ||
SUMMARY: HOW DO WE MOVE FORWARD IN THE PREVENTION OF ANASTOMOTIC HEALING COMPLICATIONS? | 138 | ||
References | 139 | ||
Is Health Services Research Important for Surgeons? | 143 | ||
INTRODUCTION | 143 | ||
SIGNIFICANCE OF HEALTH SERVICES RESEARCH FOR SURGEONS | 144 | ||
Defining health services research | 144 | ||
A framework for health sciences research: structure, process, and outcomes | 144 | ||
Structure | 144 | ||
Process | 146 | ||
Outcomes | 147 | ||
Disciplines within health services research and research modalities | 148 | ||
Patient/disease-management level | 148 | ||
Hospital level | 151 | ||
Health policy level | 154 | ||
SUMMARY | 154 | ||
References | 155 | ||
Robotic Colorectal Surgery | 157 | ||
INTRODUCTION | 157 | ||
OPERATING IN CONFINES OF NARROW BONY PELVIS | 158 | ||
IMPACT OF CONING ON CIRCUMFERENTIAL RESECTION MARGIN IN RECTAL CANCER | 159 | ||
SUTURING AND KNOT-TYING | 162 | ||
HAND-SEWN ILEOCOLIC ANASTOMOSES | 163 | ||
RECTOPEXY | 165 | ||
TRANSANAL MINIMALLY INVASIVE SURGERY | 165 | ||
TRANSANAL TOTAL MESORECTAL EXCISION | 166 | ||
SUMMARY | 167 | ||
References | 167 | ||
Ventilator Management | 173 | ||
INTRODUCTION | 173 | ||
SIGNIFICANCE | 174 | ||
Initial approach | 175 | ||
Hypoxia | 175 | ||
High pressures | 180 | ||
Dyssynchrony and comfort | 182 | ||
Ventilator liberation | 183 | ||
Present relevance and future avenues | 184 | ||
SUMMARY | 184 | ||
References | 185 | ||
Hernia Management in the Athlete | 187 | ||
Key points | 187 | ||
BACKGROUND AND EPIDEMIOLOGY OF GROIN INJURIES | 187 | ||
DIFFERENTIAL DIAGNOSIS | 189 | ||
CLINICAL EVALUATION | 191 | ||
DIAGNOSTIC EVALUATION AND IMAGING | 192 | ||
PATHOPHYSIOLOGY OF ATHLETIC PUBALGIA | 193 | ||
SURGICAL INDICATIONS AND OPERATIVE APPROACHES | 194 | ||
Inguinal hernia | 194 | ||
Athletic pubalgia | 195 | ||
ROLE OF ADDUCTOR TENOTOMY | 199 | ||
POSTOPERATIVE MANAGEMENT AND RETURN TO SPORT | 200 | ||
SUMMARY | 200 | ||
References | 201 | ||
Groin Pain After Inguinal Hernia Repair | 203 | ||
INTRODUCTION | 203 | ||
SIGNIFICANCE | 204 | ||
Definition | 204 | ||
Etiology | 204 | ||
Neuropathic pain | 203 | ||
Relevant anatomy | 205 | ||
Nonneuropathic pain | 206 | ||
Visceral pain | 206 | ||
Somatic pain | 206 | ||
Risk factors | 207 | ||
SYMPTOMATOLOGY AND DIAGNOSIS | 208 | ||
History | 208 | ||
Physical examination | 208 | ||
Diagnostic imaging and tests | 210 | ||
TREATMENT | 211 | ||
Nonsurgical management | 211 | ||
Interventional pain management | 211 | ||
Nerve blocks | 211 | ||
Neuroablative techniques | 212 | ||
Neuromodulation | 212 | ||
Surgical management | 213 | ||
Selective versus triple neurectomy | 213 | ||
Approach to open triple neurectomy | 214 | ||
Approach to endoscopic retroperitoneal triple neurectomy | 215 | ||
Surgical management of chronic postoperative inguinal pain with recurrence or meshoma | 215 | ||
FUTURE DIRECTIONS | 215 | ||
References | 217 | ||
Evolution of Sepsis Management | 221 | ||
Key points | 221 | ||
DEFINITION OF SEPSIS | 221 | ||
PATHOBIOLOGY OF SEPSIS | 223 | ||
THERAPY FOR SEPSIS | 225 | ||
EARLY GOAL-DIRECTED THERAPY | 225 | ||
EFFICACY OF EARLY GOAL-DIRECTED THERAPY | 227 | ||
WHY DID EARLY GOAL-DIRECTED THERAPY FAIL? | 228 | ||
Changes in sepsis management over time | 228 | ||
Efficacy of individual elements of early goal-directed therapy | 229 | ||
Central venous pressure | 221 | ||
Mean arterial pressure | 229 | ||
Central venous oxygen saturation | 230 | ||
Transfusion | 230 | ||
PERSONALIZED CARE: TODAY | 230 | ||
PERSONALIZED CARE: THE FUTURE | 232 | ||
SUMMARY | 232 | ||
References | 232 | ||
Current Status of Carotid Stenting Versus Endarterectomy | 235 | ||
Key points | 235 | ||
REVIEW OF RANDOMIZED CONTROLLED CAROTID TRIALS (CAROTID ARTERY STENTING VS CAROTID ENDARTERECTOMY) | 235 | ||
The Carotid and Vertebral Artery Transluminal Angioplasty Study | 236 | ||
The Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Trial | 236 | ||
The Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis Trial | 237 | ||
The Stent-supported Percutaneous Angioplasty of the Carotid Artery Versus Endarterectomy Trial | 237 | ||
The Carotid and Vertebral Artery Transluminal Angioplasty Study 2 (also called International Carotid Stenting Study) | 238 | ||
Carotid Revascularization Endarterectomy Versus Stenting Trial | 238 | ||
Metaanalysis of Clinical Trials: Carotid Artery Stenting Versus Carotid Endarterectomy | 240 | ||
CAROTID ARTERY STENTING RESULTS IN THE REAL WORLD | 243 | ||
Outcomes After Carotid Artery Stenting in Medicare Beneficiaries, 2005 to 2009 (Carotid Artery Stenting Linked to High Real ... | 244 | ||
Comparison of Trends and Outcomes of Carotid Artery Stenting and Carotid Endarterectomy in the United States (2001–2010) | 244 | ||
Comparative Effectiveness of Carotid Revascularization Treatment: Evidence from a National Hospital Discharge Database | 246 | ||
Systematic Review and Metaanalysis of Carotid Artery Stenting Versus Endarterectomy for Carotid Stenosis: a Chronologic and ... | 247 | ||
Repeat Carotid Endarterectomy Versus Carotid Artery Stenting for Patients with Restenosis After Carotid Endarterectomy: Sys ... | 247 | ||
Society for Vascular Surgery Carotid Vascular Registry: Carotid Artery Stenting Versus Carotid Endarterectomy Outcome Compa ... | 248 | ||
Other Negative Predictors for Carotid Artery Stenting | 248 | ||
Effect of Age on Carotid Artery Stenting Results | 248 | ||
Effect of Gender on Carotid Artery Stenting Results | 249 | ||
Carotid Artery Stenting Is More Costly than Carotid Endarterectomy | 249 | ||
Should the United States Centers for Medicare and Medicaid Services Extend Reimbursement Indications for Carotid Artery Ste ... | 249 | ||
Guidelines of Various Specialties in Treating Carotid Artery Stenosis and the Differences in Their Recommendations for the ... | 250 | ||
For Symptomatic Carotid Artery Stenosis | 251 | ||
For Asymptomatic Carotid Artery Stenosis | 251 | ||
Recent Carotid Artery Stenting Data: Using the Enroute Transcarotid System (Investigation of Transcarotid CAS With Dynamic ... | 252 | ||
Final Recommendation for the Role of Carotid Artery Stenting Versus Carotid Endarterecomy | 252 | ||
SUMMARY | 253 | ||
References | 253 |